T7T7 gene delivery systems - Indevus Pharmaceuticals
Latest Information Update: 29 Oct 1999
At a glance
- Originator Ohio University
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 29 Oct 1999 Discontinued-Preclinical for Solid tumours in USA (Injection)
- 31 Mar 1998 Preclinical development for Solid tumours in USA (Injection)
- 31 Mar 1998 New profile